Zobrazeno 1 - 10
of 1 871
pro vyhledávání: '"Vehling-Kaiser U"'
Autor:
Alig, A.H.S., Modest, D.P., Stintzing, S., Heinrich, K., Geissler, M., Fischer von Weikersthal, L., Decker, T., Vehling-Kaiser, U., Held, S., Moosmann, N., Stahler, A., Tannapfel, A., Giessen-Jung, C., Jung, A., Weiss, L., Heinemann, V.
Publikováno v:
In ESMO Open September 2024 9(9)
Autor:
Boukovala, M., Modest, D.P., Ricard, I., Fischer von Weikersthal, L., Decker, T., Vehling-Kaiser, U., Uhlig, J., Schenk, M., Freiberg-Richter, J., Peuser, B., Denzlinger, C., Peveling Genannt Reddemann, C., Graeven, U., Schuch, G., Schwaner, I., Heinrich, K., Neumann, J., Jung, A., Held, S., Stintzing, S., Heinemann, V., Michl, M.
Publikováno v:
In ESMO Open May 2024 9(5)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Weiss, L., Karthaus, M., Riera-Knorrenschild, J., Kretzschmar, A., Welslau, M., Vehling-Kaiser, U., Pelz, H., Ettrich, T.J., Hess, J., Reisländer, T., Klein, A., Heinemann, V.
Publikováno v:
In ESMO Open February 2022 7(1)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kaiser U; Clinic and Polyclinic for Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Kaltenhauser S; Institute for Diagnostic Radiology and Interdisciplinary Ultrasound, University Hospital Regensburg, Regensburg, Germany., Kaiser F; MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany., Vehling-Kaiser U; MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany., Herr W; Clinic and Polyclinic for Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Stroszczynski C; Institute for Diagnostic Radiology and Interdisciplinary Ultrasound, University Hospital Regensburg, Regensburg, Germany., Becker C; Institute for Diagnostic Radiology and Interdisciplinary Ultrasound, University Hospital Regensburg, Regensburg, Germany., Dropco I; Clinic and Polyclinic for Surgery, University Hospital Regensburg, Regensburg, Germany., Jung EM; Institute for Diagnostic Radiology and Interdisciplinary Ultrasound, University Hospital Regensburg, Regensburg, Germany.
Publikováno v:
Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2024 Sep 21. Date of Electronic Publication: 2024 Sep 21.
Autor:
Simon F; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Ligtvoet R; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Robrecht S; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Cramer P; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Kutsch N; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Fürstenau M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Goede V; St Marienhospital Cologne, Oncogeriatric Unit, Department of Geriatric Medicine, Cologne, Germany., von Tresckow J; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Langerbeins P; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Fink AM; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Huber H; Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Tausch E; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Schneider C; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Wendtner CM; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Ritgen M; Department II of Internal Medicine, University of Schleswig-Holstein, Kiel, Germany., Dreyling M; Department of Medicine III, Ludwig-Maximilians-University Hospital, Munich, Germany., Müller L; Study Centrum Unter Ems, Practice for Oncology and Hematology, Leer, Germany., Jacobasch L; Praxis of Haematology and Oncology, Dresden, Germany., Heinz WJ; Caritas-Krankenhaus Bad Mergentheim, Medizinische Klinik II, Bad Mergentheim, Germany., Vehling-Kaiser U; Outpatient Clinic, Landshut, Germany., Sivcheva L; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria., Böttcher S; Department of Medicine III Hematology, Oncology and Palliative Care, University Hospital, Rostock, Germany., Dreger P; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Illmer T; Praxis of Haematology and Oncology, Dresden, Germany., Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Staber PB; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria., Stilgenbauer S; Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Niemann CU; Department of Hematology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Kater AP; Academic Medical Department of Hematology, Cancer Center, Amsterdam, University of Amsterdam, Amsterdam, the Netherlands., Fischer K; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Eichhorst B; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Hallek M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Al-Sawaf O; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 23, pp. JCO2401192. Date of Electronic Publication: 2024 Aug 23.
Autor:
Kutsch N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Giza A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Stumpf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Federhen A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Stoltefuß A; Evangelisches Krankenhaus Hamm, Hamm, Germany., Vehling-Kaiser U; ÜBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany., Koenigsmann M; Onkologisches Ambulanzzentrum Hannover., Tausch E; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Schneider C; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Stilgenbauer S; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Illmer T; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany., Schlag R; Hämatologisch-Onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany., Dörfel S; Onkozentrum Dresden Freiberg, Dresden, Germany., Gaska T; Klinik für Hämatologie und Onkologie, Brüderkrankenhaus St. Josef, Paderborn, Germany., Kiehl M; Medizinische Klinik I, Klinikum Frankfurt/Oder, Frankfurt, Germany., Müller-Hagen S; Praxis für Hämatologie und Onkologie in Hamburg, Hamburg, Germany., Moorahrend E; Zentrum für Hämatologie und Onkologie MVZ Porta Westfalica, Porta Westfalica, Germany., Linde H; MVZ für Blut und Krebserkrankungen Potsdam, Potsdam, Germany., Schlenska-Lange A; Barmherzige Brüder Krankenhaus Regensburg, Regensburg, Germany., von Tresckow J; Universitätsklinikum Essen, Essen, Germany., Fischer K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Eichhorst B; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Fink AM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 235-241. Date of Electronic Publication: 2024 May 01.
Autor:
Kutsch N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany., Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany., Fink A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany., Lange E; Department of Hematology and Oncology Evangelical Hospital Hamm Hamm Germany., Weide R; Practice for Hematology and Oncology Koblenz Germany., Kiehl MG; Department of Internal Medicine Frankfurt (Oder) General Hospital Frankfurt/Oder Germany., Sökler M; Department II of Internal Medicine University Hospital Tübingen Tübingen Germany.; Department of Hematology and Oncology Hospital STS AG Thun Thun Switzerland., Schlag R; Practice for Oncology Würzburg Germany., Vehling-Kaiser U; Oncology and Palliative Care, Dayclinic Landshut Landshut Germany., Köchling G; Private Oncology Practice Villingen-Schwenningen Germany., Plöger C; Private Oncology Practice Mannheim Germany., Gregor M; Division of Hematology Cantonal Hospital of Lucerne Lucerne Switzerland., Plesner T; Department of Hematology and University of Southern Denmark Vejle Hospital Vejle Denmark., Clausen MR; Department of Hematology and University of Southern Denmark Vejle Hospital Vejle Denmark., Oschlies I; Hematopathology Section Christian-Albrechts-University Kiel Kiel Germany., Ritgen M; Department II of Internal Medicine University of Schleswig-Holstein Kiel Germany., Herling M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany.; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology University Hospital Leipzig Leipzig Germany., Fischer K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany., Döhner H; Department III of Internal Medicine University Hospital of Ulm Ulm Germany., Wendtner CM; Department III of Internal Medicine University Hospital, LMU Munich Germany., Kreuzer KA; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany., Stilgenbauer S; Department of Hematology and Oncology Hospital STS AG Thun Thun Switzerland.; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology University Hospital Leipzig Leipzig Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany., Böttcher S; Department III of Internal Medicine Medicine-Hematology/Oncology/Palliative Care Rostock University Medical Center Rostock Germany., Klapper W; Hematopathology Section Christian-Albrechts-University Kiel Kiel Germany., Eichhorst B; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany.
Publikováno v:
HemaSphere [Hemasphere] 2024 Jul 24; Vol. 8 (7), pp. e126. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).